Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Pulse Biosciences, Inc.    PLSE

PULSE BIOSCIENCES, INC.

(PLSE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization1 236279429--
Entreprise Value (EV)1 236279429429429
P/E ratio -5,21x----
Yield -----
Capitalization / Revenue ---165x17,3x
EV / Revenue ---165x17,3x
EV / EBITDA -----
Price to Book -----
Nbr of stocks (in thousands) 20 57920 78825 342--
Reference price (USD) 11,513,416,916,916,9
Last update 02/07/201903/16/2020---
1
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2018 2019 2020 2021 2022
Net sales1 ---2,6024,7
EBITDA -----
Operating profit (EBIT)1 --48,0-47,8-46,5-33,5
Operating Margin ----1 789%-136%
Pre-Tax Profit (EBT) -----
Net income -37,5----
Net margin -----
EPS -2,20----
Dividend per Share -----
Last update 02/07/201903/16/2020---
1 USD in Million
Estimates
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022
Net Debt -----
Net Cash position -----
Leverage (Debt / EBITDA) -----
Free Cash Flow -----
ROE (Net Profit / Equities) -----
Shareholders' equity -----
ROA (Net Profit / Asset) -----
Assets -----
Book Value Per Share -----
Cash Flow per Share -----
Capex -----
Capex / Sales -----
Last update 02/07/201903/16/2020---
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
429 032 272
Number of employees
82
Free-Float
51,8%
Free-Float capitalization (USD)
222 412 881
Avg. Exchange 20 sessions (USD)
1 487 702
Average Daily Capital Traded
0,35%
EPS & Dividend